Abstract Details

Title Comparing the healthcare utilization and direct medical costs in newly diagnosed epilepsy patients and a comparator non-epilepsy population: a US database analysis

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) S34 - (-)

Poster/Presentation
Number 002

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
R E. Faught, Jr., MD, FAAN (Emory University) PRESENTER	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma.
Sandra L. Helmers, MD, FAAN (Emory Universtiy)	No disclosure on file
David J. Thurman, MD, FAAN	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file